Where China's Top Domestic & Multinational Clinical Development Leaders Meet
Last year's 10th Anniversary ChinaTrials Summit focused its discussion around the slew of new policy changes that were meant to pave the way to increased development times and improved safety oversight for the development of new innovative medicines for China and the World. While these sessions were more broad and general in nature, they helped our audience to begin to chart where the next 10 years of drug development in China might look like.
This year, we will be diving deeper and more specific into the topics that will drive innovative drug development from China for years to come. With so many moving targets in regulatory policy, clinical talent, funding to bring drugs through the clinic and drug safety, we will aim this year's content squarely on strategies to keep you and your team at forefront to follow and hit these moving targets accurately and effectively in the next years.